Preventive and curative effects of probiotics in atopic patients

被引:15
作者
Bongaerts, GPA
Severijnen, RSVM
机构
[1] Radboud Univ, Nijmegen Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ, Nijmegen Med Ctr, Dept Paediat Surg, Nijmegen, Netherlands
关键词
D O I
10.1016/j.mehy.2004.10.018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Normally, the transport of allergens through the intestinal epithelia to the blood is limited. It is hypothesised that if these compounds arrive in the blood circulation, they must percolate through the epithelial, cell Layer. Thus, food allergy (and thus atopic eczema) implies an increased intercellular leakage of the gut wall. Such increased intercellular leakage is thought to be caused by a slightly changed cellular morphology due to a slight cytopathologic effect because of both a Limited decay of the cytoskeleton and a slightly reduced turgor. These events may be due to a reduced production of intracellular metabolic energy in the epithelial cells due to an increased concentration of familiar, frequently occurring, potentially toxic bacterial, metabolites, i.e., D-lactic acid and/or ethanol. In this hypothesis we suggest that adequate probiotics can (i) prevent the increased characteristic intestinal permeability of children with atopic eczema and food allergy, (ii) can thus prevent the uptake of allergens, and (iii) finally can prevent the expression of the atopic constitution. The use of adequate probiotic lactobacilli, i.e., homolactic and/or facultatively heterolactic L-lactic acid-producing lactobacilli, reduces the intestinal amounts of the bacteria(, toxic metabolites, D-tactic acid and ethanol by fermentative production of merely the non-toxic L-Lactic acid from glucose. Thus, it is thought that beneficial probiotic micro-organisms promote gut barrier function and both undo and prevent unfavourable intestinal micro-ecological alterations in allergic individuals. (c) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1089 / 1092
页数:4
相关论文
共 10 条
[1]   Lactobacilli and acidosis in children with short small bowel [J].
Bongaerts, G ;
Bakkeren, J ;
Severijnen, R ;
Sperl, W ;
Willems, H ;
Naber, T ;
Wevers, R ;
van Meurs, A ;
Tolboom, J .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2000, 30 (03) :288-293
[2]  
BONGAERTS G, 1995, CLIN CHEM, V41, P107
[3]   Role of bacteria in the pathogenesis of short bowel syndrome-associated D-lactic acidemia [J].
Bongaerts, GPA ;
Tolboom, JJM ;
Naber, AHJ ;
Sperl, WJK ;
Severijnen, RSVM ;
Bakkeren, JAJM ;
Willems, JL .
MICROBIAL PATHOGENESIS, 1997, 22 (05) :285-293
[4]   New strategies in antimicrobial therapy [J].
Bongaerts, GPA ;
Severijnen, RSVM .
MEDICAL HYPOTHESES, 2001, 56 (02) :178-180
[5]   The beneficial, antimicrobial effect of probiotics [J].
Bongaerts, GPA ;
Severijnen, RSVM .
MEDICAL HYPOTHESES, 2001, 56 (02) :174-177
[6]   Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing [J].
Kalliomäki, M ;
Kirjavainen, P ;
Eerola, E ;
Kero, P ;
Salminen, S ;
Isolauri, E .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (01) :129-134
[7]   Probiotics in primary prevention of atopic disease:: a randomised placebo-controlled trial [J].
Kalliomäki, M ;
Salminen, S ;
Arvilommi, H ;
Kero, P ;
Koskinen, P ;
Isolauri, E .
LANCET, 2001, 357 (9262) :1076-1079
[8]   Natural course of sensitization to food and inhalant allergens during the first 6 years of life [J].
Kulig, M ;
Bergmann, R ;
Klettke, U ;
Wahn, V ;
Tacke, U ;
Wahn, U .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (06) :1173-1179
[9]   Serum IgE levels during the first 6 years of life [J].
Kulig, M ;
Tacke, U ;
Forster, J ;
Edenharter, G ;
Bergmann, R ;
Lau, S ;
Wahn, V ;
Zepp, F ;
Wahn, U .
JOURNAL OF PEDIATRICS, 1999, 134 (04) :453-458
[10]   METABOLISM OF D-ALPHA-HYDROXY ACIDS IN ANIMAL TISSUES [J].
TUBBS, PK .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1965, 119 (A3) :920-&